Search Results - "Pena, Ryan"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Peripartum management of HLA alloimmune platelet refractoriness by Peña, Jeremy Ryan, Sudhof, Leanna, O'Brien, Barbara

    Published in Transfusion (Philadelphia, Pa.) (01-07-2018)
    “…BACKGROUND Platelet (PLT) refractoriness presents a challenging problem for transfusion support, especially in the perioperative setting, where there is…”
    Get full text
    Journal Article
  2. 2
  3. 3

    A Review of Laboratory Practices Using the HLA-B27 Survey by the College of American Pathologists: How Important Is Allele-Level Typing? by Peña, Jeremy Ryan Andrew, Fung, Mark K, Gandhi, Manish J

    “…Ankylosing spondylitis (AS) is an autoimmune disorder with a strong genetic risk, especially with HLA-B27. Clinical testing for HLA-B27 has been used to help…”
    Get full text
    Journal Article
  4. 4

    Use of Human Leukocyte Antigen (HLA)-Incompatible Platelet Units in HLA Platelet-Refractory Patients With Limited Number of or Low-Level HLA Donor-Specific Antibodies Results in Permissive Transfusions by Cone Sullivan, Jensyn, Peña, Jeremy Ryan

    “…In human leukocyte antigen (HLA)-mediated alloimmune platelet refractoriness, HLA-incompatible platelets may produce adequate posttransfusion corrected count…”
    Get full text
    Journal Article
  5. 5

    HLA-DQ Mismatching and Kidney Transplant Outcomes by Leeaphorn, Napat, Pena, Jeremy Ryan A, Thamcharoen, Natanong, Khankin, Eliyahu V, Pavlakis, Martha, Cardarelli, Francesca

    “…Recent evidence suggests that HLA epitope-mismatching at HLA-DQ loci is associated with the development of anti-DQ donor-specific antibodies and adverse graft…”
    Get full text
    Journal Article
  6. 6

    Utilization management in the blood transfusion service by Peña, Jeremy Ryan Andrew, Dzik, Walter “Sunny”

    Published in Clinica chimica acta (01-01-2014)
    “…The scope of activity of the Blood Transfusion Service (BTS) makes it unique among the clinical laboratories. The combination of therapeutic and diagnostic…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Anti‐HLA antibody testing in hematology patients by Peña, Jeremy Ryan A., Saidman, Susan L.

    Published in American journal of hematology (01-04-2015)
    “…Anti‐human leukocyte antigens (HLA) antibodies can adversely impact the care of hematology patients. In particular, HLA antibody testing provides important…”
    Get full text
    Journal Article
  9. 9

    Anti‐HLA alloantibodies in surgical patients refractory to platelet transfusion by Peña, Jeremy Ryan A., Saidman, Susan L., Girouard, Timothy C., Meister, Erin, Dzik, Walter H., Makar, Robert S.

    Published in American journal of hematology (01-09-2014)
    “…Alloimmune platelet refractoriness (alloPR) among actively bleeding surgical patients with thrombocytopenia represents a life‐threatening problem. Here we…”
    Get full text
    Journal Article
  10. 10

    Routine Solid Phase Multiplex Anti-HLA Antibody Tests Predict Platelet Refractoriness by Peña, Jeremy Ryan A, Makar, Robert S

    Published in American journal of clinical pathology (05-07-2019)
    “…No validated screening methods identify patients at risk for human leukocyte antigen (HLA) alloimmune-mediated platelet refractoriness (alloPR). We determined…”
    Get full text
    Journal Article
  11. 11
  12. 12

    153-P: HIGH-RESOLUTION TYPING BY NEXT-GENERATION SEQUENCING IN A CLINICAL HLA LABORATORY by A. Pena, J. Ryan, Berces, Attila, Kent, Heather, Major, Endre, Hague, Tim, Saidman, Susan L.

    Published in Human immunology (01-11-2013)
    “…The aim of this study is to test the feasibility and compare the analytical performance of HLA typing of clinical and proficiency testing samples using…”
    Get full text
    Journal Article
  13. 13

    153-P by A. Pena, J. Ryan, Berces, Attila, Kent, Heather, Major, Endre, Hague, Tim, Saidman, Susan L

    Published in Human immunology (01-11-2013)
    “…Aim The aim of this study is to test the feasibility and compare the analytical performance of HLA typing of clinical and proficiency testing samples using…”
    Get full text
    Journal Article
  14. 14
  15. 15

    P119 Single-center experience in routine post-transplant antibody testing of kidney transplant recipients without pre-existing donor specific anti-HLA antibodies by Peña, J. Ryan, Cardarelli, Francesca, Khankin, Eliyahu, Pavlakis, Martha

    Published in Human immunology (01-09-2016)
    “…Aim Antibody-mediated rejection (AMR) of kidney allografts is thought to follow a stepwise process which includes alloimmune recognition, followed by…”
    Get full text
    Journal Article
  16. 16

    P105 Single-center experience in routine post-transplant antibody testing of risk-stratified kidney transplant recipients by Dinh, Anh, Cardarelli, Francesca, Khankin, Eliyahu, Pavlakis, Martha, Peña, J. Ryan

    Published in Human immunology (01-09-2017)
    “…Preformed (pf) and de novo(dn) donor-specific antibodies (DSA) are associated with antibody mediated rejection (AMR). We previously showed that ∼6% of low-risk…”
    Get full text
    Journal Article
  17. 17

    Complement-dependent cytotoxicity crossmatch by Peña, Jeremy Ryan, Fitzpatrick, Donna, Saidman, Susan L

    “…The complement-dependent cytotoxic crossmatch is an informative test that detects alloantibodies in pre- and post-transplant patients, which may dictate…”
    Get more information
    Journal Article
  18. 18

    Peripartum management of HLA alloimmune platelet refractoriness by Peña, Jeremy Ryan, Sudhof, Leanna, O'Brien, Barbara

    Published in Transfusion (01-07-2018)
    “…BACKGROUNDPlatelet (PLT) refractoriness presents a challenging problem for transfusion support, especially in the perioperative setting, where there is urgency…”
    Get full text
    Report